Results 31 to 40 of about 3,106,214 (162)

Severe Anti-N-Methyl-D-Aspartate Receptor Encephalitis Under Immunosuppression After Liver Transplantation

Frontiers in Neurology, 2019
Anti-NMDA receptor encephalitis is a rare and often therapy-responsive autoimmune disease that usually affects young adults and causes neuropsychiatric symptoms.
Franz Felix Konen, Philipp Schwenkenbecher, Konstantin Fritz Jendretzky, Martin Werner Hümmert, Florian Wegner, Martin Stangel, Kurt-Wolfram Sühs, Thomas Skripuletz   +7 more
doaj   +1 more source

PEDIATRIC ANTI-NMDA RECEPTOR ENCEPHALITIS: A CASE REPORT [PDF]

, 2023
Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an autoimmune inflammation of the brain parenchyma mediated with autoantibodies against the NMDA receptors in the neuronal cells.
JONUZI, ALBA, ALEKSI, KRISTI, BUSHATI, AIDA, SHEHU, ARMAND, ASLLANAJ, LURJANA, KUMARAKU, AFERDITA TAKO   +5 more
core   +1 more source

Anti-NMDA receptor encephalitis presenting as fever with undetermined cause

International Journal of Infectious Diseases, 2022
Autoimmune encephalitis is a rare disease, which should be differentiated from aseptic encephalitis. Possessing anti-N-methyl-D-aspartate (NMDA) receptor autoantibody is the leading cause of autoimmune encephalitis.
Chih-Wei Liang, Tun-Chieh Chen
doaj   +1 more source

Case of autoimmune polyendocrine syndrome type 3 complicated with anti‐N‐methyl‐D‐aspartic acid‐receptor encephalitis

Journal of Diabetes Investigation, 2021
Anti‐N‐methyl‐D‐aspartate receptor (NMDA‐R) encephalitis is an autoimmune disorder in which autoantibodies in the limbic system bind to GluN1 subunits of NMDA‐Rs in the brain.
Akira Kurozumi, Yosuke Okada, Kosuke Nishio, Yoshiya Tanaka   +3 more
doaj   +1 more source

Psychiatric Presentation of Anti-NMDA Receptor Encephalitis

, 2020
Background: Anti-N-methyl D-aspartate (NMDA) receptor encephalitis is an autoimmune condition characterized by neuropsychiatric symptoms, including epileptic seizures, movement disorders, autonomic instability, disturbances of consciousness, paranoia ...
Endres, Dominique, Venhoff, Nils, Prüss, Harald, Kern, Winfried, Rauer, Sebastian, Domschke, Katharina, Egger, Karl, Nickel, Kathrin, Maier, Simon J., Heidt, Timo, Runge, Kimon, Süß, Patrick, Meyer, Philipp T., Feige, Bernd, Tebartz van Elst, Ludger   +14 more
core   +1 more source

Anti-N-Methyl-d-Aspartate Receptor Encephalitis in a Patient with Alcoholism: A Rare Case Report

Frontiers in Psychiatry, 2017
Anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis, the most common type of autoimmune encephalitis, is characterized by autoantibodies against NMDA receptor. Patients with anti-NMDAR encephalitis also present with various non-specific symptoms,
Yangyang Li, Qiuling Wang, Chuanxin Liu, Chuanxin Liu, Yili Wu, Yili Wu, Yili Wu   +6 more
doaj   +1 more source

Anti-NMDA receptor encephalitis with neurologic sequelae refractory to conservative therapy with complete response to adjuvant therapy

Gynecologic Oncology Reports, 2020
Background: Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis has been described in increasing frequency in association with benign, mature ovarian teratoma.
Aaron Nizam, Andrew W. Menzin, Jill S. Whyte   +2 more
doaj   +1 more source

Ofatumumab, a fully human anti-CD20 monoclonal antibody, in the treatment of severe refractory Anti-N-methyl-D-aspartate receptor encephalitis: Two case reports

Annals of Indian Academy of Neurology, 2023
Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is a type of autoimmune encephalitis (AE) characterized by antibodies against NMDA receptor. As the most common AE, anti-NMDAR encephalitis affects 54% ~ 80% of patients with AE.
Hongfei Xue, Yushu Jiang, Lingzhi Qin, Xiaojuan Wang, Milan Zhang, Shuhua Dai, Yongshi Teng, Jiajia Xu, Wei Li   +8 more
doaj   +1 more source

Anti-NMDA receptor encephalitis after yellow fever vaccination : a case report

, 2021
Dear Editor, As most of us are aware, anti-N-methyl D-aspartate (NMDA) receptor encephalitis is a potentially fatal limbic encephalitis. In several cases, an underlying tumor or a preceding viral infection can be withheld.
Reynders, Tatjana, Coeckelbergh, Evelien
core   +1 more source

Early Clinical and Cerebrospinal Fluid Predictors of 1‐Year Recurrence in Autoimmune GFAP Astrocytopathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune glial fibrillary acidic protein astrocytopathy (GFAP‐A) is an inflammatory central nervous system disorder with variable outcomes. Relapse occurs in a subset of patients, but early predictors remain unclear. We aimed to identify admission‐available features associated with 1‐year recurrence and develop an interpretable ...
Qingting Hong, Yuping Xiao, Yuhan Wu, Ziyuan Huang, Weishan Liang, Li Xiao, Yaqing Shu, Tingting Lu, Yanyu Chang, Wei Qiu, Yuge Wang   +10 more
wiley   +1 more source